General Information
Drug ID
DR01347
Drug Name
Raloxifene
Synonyms
Raloxifene (extended-release, CDT)
Drug Type
Small molecular drug
Indication Osteoporosis [ICD11:FB83.1] Approved [1]
Structure
3D MOL 2D MOL
Formula
C28H27NO4S
Canonical SMILES
C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
InChI
InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2
InChIKey
GZUITABIAKMVPG-UHFFFAOYSA-N
CAS Number
CAS 84449-90-1
Pharmaceutical Properties Molecular Weight 473.6 Topological Polar Surface Area 98.2
Heavy Atom Count 34 Rotatable Bond Count 7
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
6.1
PubChem CID
5035
PubChem SID
9437 ,831017 ,5392969 ,7890214 ,7980482 ,8153100 ,11111733 ,11111734 ,11364773 ,11367335 ,11369897 ,11372937 ,11375497 ,11378062 ,11466890 ,11468010 ,11486560 ,14834427 ,24277274 ,26705265 ,29224106 ,46506514 ,46519463 ,47213213 ,47365304 ,47662399 ,47810849 ,47810850 ,48035235 ,48185088 ,48259344 ,48416509 ,49698670 ,50065297 ,50105675 ,50139488 ,50898374 ,53788657 ,56310724 ,56312953 ,56313701 ,56352882 ,56427219 ,57322575 ,90341181 ,91148450 ,92308782 ,93165668 ,93166953 ,96025151
ChEBI ID
CHEBI:8772
TTD Drug ID
D01XBA
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Raloxifene was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl Res. 2012 Oct;160(4):298-308.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.